Mariel Therapeutics' Merger

Mariel Therapeutics raised a round of funding on March 12, 2015. Investors include Ember Therapeutics.

Mariel Therapeutics is a clinical stage therapeutic company. The company focuses on Bone Morphogenetic Protein-7 (BMP-7) and its role in Osteoarthritis (OA) and organ fibrosis, including Chronic Kidne…

Articles about Mariel Therapeutics' Merger: